With 75% of deaths related to NCDs and mental health conditions in low- and middle-income countries – accounting for 32 million lives lost each year – affordable access to key medical tools should be a necessity, not a luxury Geneva/New York, 16 December 2025 – Yesterday, nearly three months after it was first considered at … Read more
Managing diabetes is complicated. Even with access to the best tools and technology, it requires constant blood sugar level monitoring and daily treatment in the form of medication or insulin. If corporate decisions, displacement, or conflict leave a person living with diabetes without sustained access to affordable care, diabetes can quickly become complicated and life-threatening. … Read more
Bali/Geneva, 13 November 2024 – At the premier global conference on tuberculosis (TB), the annual Union World Conference on Lung Health, taking place in Bali, Indonesia, Christophe Perrin, TB Advocacy Pharmacist at MSF’s Access Campaign, was invited to present on Access to Medicines and Diagnostics during a plenary session. This is the first ever time … Read more
Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali, Indonesia, over 70 TB activists, including Doctors Without Borders/Medecins Sans Frontieres (MSF), took the stage during the opening ceremony to … Read more
80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices. Geneva/Johannesburg, 11 November 2024 – Ahead of World Diabetes Day, Médecins Sans Frontières/Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action … Read more
US test maker Cepheid and parent corporation Danaher have ignored global calls for price reductions and have broken their promise from one year ago to be transparent about what it costs to make their medical tests Washington, DC, 17 October 2024 — Today, the international medical humanitarian organisation Doctors Without Borders/Medecins Sans Frontieres (MSF), alongside … Read more
Too many children with TB are neither tested nor treated, with many countries failing at the first hurdle: updating policy guidelines in line with WHO recommendations. Geneva, 15 October 2024 – A new report released today by Médecins Sans Frontières/Doctors Without Borders (MSF), shows that children with tuberculosis (TB) continue to be left behind in the … Read more
Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention Shot Munich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for immediate global action to break Gilead’s monopoly on lenacapavir, in response to new data showing that generic lenacapavir can be … Read more
Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without Borders (MSF) was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & … Read more
The patent withdrawal is a result of an unprecedented investigation by South Africa’s Competition Commission into J&J We welcome today’s news that following the Competition Commission’s investigation initiation into anti-competitive practice, J&J has officially withdrawn its secondary patents in South Africa on the lifesaving TB drug bedaquiline, opening up generic competition in South Africa. Candice … Read more